Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $506.21 million. The enterprise value is $411.54 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 204.94 million shares outstanding. The number of shares has increased by 203.71% in one year.
| Current Share Class | 204.94M |
| Shares Outstanding | 204.94M |
| Shares Change (YoY) | +203.71% |
| Shares Change (QoQ) | +15.03% |
| Owned by Insiders (%) | 13.21% |
| Owned by Institutions (%) | 56.47% |
| Float | 126.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.71 |
| Forward PS | 50.83 |
| PB Ratio | 5.70 |
| P/TBV Ratio | 5.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.71.
| Current Ratio | 5.51 |
| Quick Ratio | 5.38 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -104.02 |
Financial Efficiency
Return on equity (ROE) is -114.77% and return on invested capital (ROIC) is -63.36%.
| Return on Equity (ROE) | -114.77% |
| Return on Assets (ROA) | -27.42% |
| Return on Capital (ROIC) | -63.36% |
| Revenue Per Employee | $190,673 |
| Profits Per Employee | -$437,923 |
| Employee Count | 52 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.95% in the last 52 weeks. The beta is 0.41, so TSHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +41.95% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 2.42 |
| Relative Strength Index (RSI) | 62.61 |
| Average Volume (20 Days) | 7,221,720 |
Short Selling Information
The latest short interest is 17.64 million, so 8.61% of the outstanding shares have been sold short.
| Short Interest | 17.64M |
| Short Previous Month | 20.70M |
| Short % of Shares Out | 8.61% |
| Short % of Float | 13.99% |
| Short Ratio (days to cover) | 10.60 |
Income Statement
In the last 12 months, TSHA had revenue of $9.92 million and -$22.77 million in losses. Loss per share was -$0.10.
| Revenue | 9.92M |
| Gross Profit | 9.92M |
| Operating Income | -82.49M |
| Pretax Income | -118.01M |
| Net Income | -22.77M |
| EBITDA | -81.18M |
| EBIT | -82.49M |
| Loss Per Share | -$0.10 |
Full Income StatementBalance Sheet
The company has $157.69 million in cash and $63.02 million in debt, giving a net cash position of $94.67 million or $0.46 per share.
| Cash & Cash Equivalents | 157.69M |
| Total Debt | 63.02M |
| Net Cash | 94.67M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | 88.80M |
| Book Value Per Share | 0.43 |
| Working Capital | 132.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$79.03 million and capital expenditures -$393,000, giving a free cash flow of -$79.43 million.
| Operating Cash Flow | -79.03M |
| Capital Expenditures | -393,000 |
| Free Cash Flow | -79.43M |
| FCF Per Share | -$0.39 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -831.93% and -229.67%.
| Gross Margin | 100.00% |
| Operating Margin | -831.93% |
| Pretax Margin | -229.67% |
| Profit Margin | -229.67% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -513.85% |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -203.71% |
| Shareholder Yield | -203.71% |
| Earnings Yield | -4.50% |
| FCF Yield | -15.69% |
Analyst Forecast
The average price target for TSHA is $6.63, which is 168.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.63 |
| Price Target Difference | 168.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 58.83% |
| EPS Growth Forecast (5Y) | -20.45% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -2.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.23 |
| Piotroski F-Score | 1 |